Andrea Janegova

Dr. Andrea Janegova

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011
Verified
Journal Article
Closed access
AJAndrea Janegova
Andrea Janegova
PJPavol Janega
Pavol Janega
DID Ilencíková
D Ilencíková
PBPavel Babal
Pavel Babal

24 February 2025 in COVID
Verified
Journal Article
Open access
PDF file
LKLucia Krivosikova
Lucia Krivosikova
MPMichal Palkovic
Michal Palkovic
PJPavol Janega
Pavol Janega
Kristina Mikus KuracinovaKristina Mikus Kuracinova
Kristina Mikus Kuracinova
AJAndrea Janegova
Andrea Janegova
PBPavel Babal
Pavel Babal
The early introduction of strict measures during the first wave of COVID-19 in Slovakia resulted in a low number of fatal cases. Most of them (27/28) were autopsied with microscopic evaluation focusing on changes in the lungs. The average age of the patients was 79. The most common microscopic finding was diffuse alveolar damage in various stages. There were statistically significant relationships between microthrombi and neutrophil count, level of C-reactive protein, and immobility. Oxygen therapy, as a factor that might cause changes typical for diffuse alveolar damage, showed statistically significant relationships with perivascular lymphocytic infiltrate, alveolar capillaritis, alveolar bleeding, and pneumocyte hyperplasia. Hyaline membranes showed a statistically significant relationship with monocyte count, and borderline statistically significant relationships with platelet count and antimalarial therapy. The level of C-reactive protein and neutrophil count seemed to be useful for predicting microthrombi formation. Interestingly, there were no statistically significant relationships between microthrombosis and anticoagulant therapy, platelet count, or level of D-dimer.